153 related articles for article (PubMed ID: 37114670)
41. Hemophagocytic lymphohistiocytosis in patients with metastatic malignant melanoma.
Stabler S; Becquart C; Dumezy F; Terriou L; Mortier L
Melanoma Res; 2017 Aug; 27(4):377-379. PubMed ID: 28471834
[TBL] [Abstract][Full Text] [Related]
42. Mixed-type autoimmune hemolytic anemia following fludarabine treatment in a patient with chronic lymphocytic leukemia/small cell lymphoma.
Vick DJ; Byrd JC; Beal CL; Chaffin DJ
Vox Sang; 1998; 74(2):122-6. PubMed ID: 9501412
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA expression in chronic lymphocytic leukemia developing autoimmune hemolytic anemia.
Ferrer G; Navarro A; Hodgson K; Aymerich M; Pereira A; Baumann T; Monzo M; Moreno C; Montserrat E
Leuk Lymphoma; 2013 Sep; 54(9):2016-22. PubMed ID: 23286334
[TBL] [Abstract][Full Text] [Related]
44. Ganglionar tuberculosis infection evolving to hemophagocytic lymphohistiocytosis after anti-programmed cell death 1 treatment for high-risk melanoma: a case report.
Costa CM; Gadotti LL; Seiwald MC; Salgues ACR; Ganem F; Nascimento ECT; Uip DE; Arrais-Rodrigues C; Munhoz RR
J Med Case Rep; 2021 Jul; 15(1):350. PubMed ID: 34233733
[TBL] [Abstract][Full Text] [Related]
45. Autoimmune hemolytic anemia associated with the use of immune checkpoint inhibitors for cancer: 68 cases from the Food and Drug Administration database and review.
Tanios GE; Doley PB; Munker R
Eur J Haematol; 2019 Feb; 102(2):157-162. PubMed ID: 30347480
[TBL] [Abstract][Full Text] [Related]
46. A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia.
Kaufman M; Limaye SA; Driscoll N; Johnson C; Caramanica A; Lebowicz Y; Patel D; Kohn N; Rai K
Leuk Lymphoma; 2009 Jun; 50(6):892-9. PubMed ID: 19391041
[TBL] [Abstract][Full Text] [Related]
47. Short communication: bendamustine-related hemolytic anemia in chronic lymphocytic leukemia.
Goldschmidt N; Gural A; Ben-Yehuda D; Gatt ME
Cancer Chemother Pharmacol; 2013 Sep; 72(3):709-13. PubMed ID: 23907444
[TBL] [Abstract][Full Text] [Related]
48. Composite peripheral T-cell lymphoma not otherwise specified, and B-cell small lymphocytic lymphoma presenting with hemophagocytic lymphohistiocytosis.
Alomari A; Hui P; Xu M
Int J Surg Pathol; 2013 Jun; 21(3):303-8. PubMed ID: 23129836
[TBL] [Abstract][Full Text] [Related]
49. Obinutuzumab in the treatment of autoimmune haemolytic anaemia and immune thrombocytopenia in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma.
Herishanu Y; Levi S; Kamdjou T; Bornstein Y; Ram R; Benyamini N; Varon D; Avivi I; Perry C
Br J Haematol; 2021 Jan; 192(1):e1-e4. PubMed ID: 33095444
[No Abstract] [Full Text] [Related]
50. Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias.
Nikitin E; Kislova M; Morozov D; Belyakova V; Suvorova A; Sveshnikova J; Vyscub G; Matveeva I; Shirokova M; Shipaeva A; Klitochenko T; Makarovskaya P; Dmitrieva E; Biderman B; Sudarikov A; Obukhova T; Samoilova O; Kaplanov K; Konstantinova T; Mayorova O; Poddubnaya I; Ptushkin V
Leukemia; 2023 Jul; 37(7):1464-1473. PubMed ID: 37202442
[TBL] [Abstract][Full Text] [Related]
51. Hemophagocytic lymphohistiocytosis (HLH) and cytokine release syndrome (CRS) in a patient with oncogene-addicted metastatic non-small cell lung cancer (NSCLC) following combination chemotherapy-immunotherapy.
Heynemann S; Vanguru V; Adelstein S; Kao S
Asia Pac J Clin Oncol; 2024 Apr; 20(2):315-318. PubMed ID: 36562695
[TBL] [Abstract][Full Text] [Related]
52. Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor-related hematological adverse events.
Zhuang J; Du J; Guo X; Zhou J; Duan L; Qiu W; Si X; Zhang L; Li Y; Liu X; Wang H; Zhou D; Zhang L
Thorac Cancer; 2020 Mar; 11(3):799-804. PubMed ID: 32017466
[TBL] [Abstract][Full Text] [Related]
53. Alemtuzumab therapy for severe autoimmune hemolysis in a patient with B-cell chronic lymphocytic leukemia.
Lundin J; Karlsson C; Celsing F
Med Oncol; 2006; 23(1):137-9. PubMed ID: 16645240
[TBL] [Abstract][Full Text] [Related]
54. Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment.
Hodgson K; Ferrer G; Pereira A; Moreno C; Montserrat E
Br J Haematol; 2011 Jul; 154(1):14-22. PubMed ID: 21534942
[TBL] [Abstract][Full Text] [Related]
55. Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).
Karlsson C; Hansson L; Celsing F; Lundin J
Leukemia; 2007 Mar; 21(3):511-4. PubMed ID: 17215854
[TBL] [Abstract][Full Text] [Related]
56. Autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia treated with 2-chlorodeoxyadenosine (cladribine).
Robak T; Błasińska-Morawiec M; Krykowski E; Hellmann A; Konopka L
Eur J Haematol; 1997 Feb; 58(2):109-13. PubMed ID: 9111592
[TBL] [Abstract][Full Text] [Related]
57. Management of melanoma in patients with chronic lymphocytic leukemia.
Archibald WJ; Meacham PJ; Williams AM; Baran AM; Victor AI; Barr PM; Sahasrahbudhe DM; Zent CS
Leuk Res; 2018 Aug; 71():43-46. PubMed ID: 30005183
[TBL] [Abstract][Full Text] [Related]
58. Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice?
Smolej L
Leuk Res; 2007 Feb; 31(2):267; author reply 268-9. PubMed ID: 16716397
[No Abstract] [Full Text] [Related]
59. Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome.
Carli G; Visco C; Falisi E; Perbellini O; Novella E; Giaretta I; Ferrarini I; Sandini A; Alghisi A; Ambrosetti A; Rodeghiero F
Ann Hematol; 2016 May; 95(6):863-70. PubMed ID: 27001309
[TBL] [Abstract][Full Text] [Related]
60. Haemophagocytic lymphohistiocytosis as a consequence of untreated B-cell chronic lymphocytic leukaemia.
Bailey C; Dearden C; Ardeshna K
BMJ Case Rep; 2017 Apr; 2017():. PubMed ID: 28446487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
